EM-703

N/A

Report date: 2026/03/06 20:02:51
NME

Base Information

Drug NameEM-703
Drug Alias NameEM-703
ClassificationSmall molecules > Heterocyclic drugs
Mechanisms of ActionHistone deacetylase modulatorsTransforming growth factor beta 1 modulatorsNuclear factor NF-kappa-B complex inhibitors
TargetsTransforming growth factor beta 1Histone deacetylaseNuclear factor NF-kappa-B complex
Therapy Area/IndicationsInflammationCystic Fibrosis
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritoryJapan
CombinationsNo
Global Highest StatusPending (Preclinical)
Highest Status in ChinaN/A
Originator CompaniesKitasato University
China Registration ClassN/A

Develop Information

Active CompaniesN/A
Inactive CompaniesNippon Medical School FoundationKitasato University
Active IndicationsN/A
Inactive IndicationsInflammationCystic Fibrosis

Other Information

ATC CodeN/A
Related LinksN/A